Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE

Brain

Volumn 127, Issue 2, 2004, Pages 294-303

  Craner, Matthew J ^b   Hains, Bryan C ^b   Lo, Albert C ^b   Black, Joel A ^b   Waxman, Stephen G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Axonal injury; Experimental allergic encephalomyelitis; Multiple sclerosis; Sodium channel; Sodium calcium exchanger

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CALCIUM ION; SODIUM CHANNEL; SODIUM ION;

ALLERGIC ENCEPHALITIS; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; CONTROLLED STUDY; DEMYELINATING DISEASE; IMMUNOCYTOCHEMISTRY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SODIUM CALCIUM EXCHANGE; SPINAL CORD;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; AXONS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MALE; MICE; MYELIN SHEATH; NERVE DEGENERATION; NERVE TISSUE PROTEINS; SODIUM CHANNELS; SODIUM-CALCIUM EXCHANGER; SPINAL CORD;

EID: 0742305831     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh032     Document Type: Article

References (66)

1. 2+ exchanger. J Neurosci 1996; 16: 545-52.
2. Arroyo EJ, Xu T, Grinspan J, Lambert S, Levinson SR, Brophy PJ, et al. Genetic dysmyelination alters the molecular architecture of the nodal region. J Neurosci 2002; 22: 1726-37.
3. Baker MD, Bostock H. Low-threshold, persistent sodium current in rat large dorsal root ganglion neurons in culture. J Neurophysiol 1997; 77: 1503-13.
4. Banik NL, Hogan EL, Hsu CY. The multimolecular cascade of spinal cord injury. Studies on prostanoids, calcium, and proteinases. Neurochem Pathol 1987; 7: 57-77.
5. Bechtold DA, Kapoor R, Smith KJ. Axonal protection mediated by flecainide therapy in experimental inflammatory demyelinating disease [abstract]. J Neurol 2002; 249 Suppl 1: 204.
6. Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Bruck W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000; 123: 1174-83.
7. Bjartmar C, Kidd G, Mork S, Rudick R, Trapp BD. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000; 48: 893-901.
8. Black JA, Dib-Hajj S, McNabola K, Jeste S, Rizzo MA, Kocsis JD, et al. Spinal sensory neurons express multiple sodium channel alpha-subunit mRNAs. Brain Res Mol Brain Res 1996; 43: 117-31.
9. Black JA, Fjell J, Dib-Hajj S, Duncan ID, O'Connor LT, Fried K, et al. Abnormal expression of SNS/PN3 sodium channel in cerebellar Purkinje cells following loss of myelin in the taiep rat. Neuroreport 1999; 10: 913-8.
10. Black JA, Renganathan M, Waxman SG. Sodium channel Na(v)1.6 is expressed along nonmyelinated axons and it contributes to conduction. Brain Res Mol Brain Res 2002; 105: 19-28.
11. Bo L, Dawson TM, Wesselingh S, Mork S, Choi S, Kong PA, et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994; 36: 778-86.
12. Boiko T, Rasband MN, Levinson SR, Caldwell JH, Mandel G, Trimmer JS, et al. Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon. Neuron 2001; 30: 91-104.
13. Bolanos JP, Almeida A, Stewart V, Peuchen S, Land JM, Clark JB, et al. Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neurochem 1997; 68: 2227-40.
14. Bostock H, Sears TA. Continuous conduction in demyelinated mammalian nerve fibres. Nature 1976; 263: 786-7.
15. Bostock H, Sears TA. The internodal axon membrane: electrical excitability and continuous conduction in segmental demyelination. J Physiol 1978; 280: 273-301.
16. Brosnan CF, Battistini L, Raine CS, Dickson DW, Casadevall A, Lee SC. Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci 1994; 16: 152-61.
17. Brown GC, Bolanos JP, Heales SJ, Clark JB. Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration. Neurosci Lett 1995; 193: 201-4.
18. Buki A, Okonkwo DO, Wang KK, Povlishock JT. Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci 2000; 20: 2825-34.
19. Caldwell JH, Schaller KL, Lasher RS, Peles E, Levinson SR. Sodium channel Na(v)1.6 is localized at nodes of ranvier, dendrites, and synapses. Proc Natl Acad Sci USA 2000; 97: 5616-20.
20. Charcot J-M. Histologie de la sclérose en plaques. Gaz Hop (Paris) 1868; 41: 554-7, 557-8, 566.
21. Chung K, Langford LA, Coggeshall RE. Primary afferent and propriospinal fibres in the rat dorsal and dorsolateral funiculi. J Comp Neurol 1987; 263: 68-75.
22. Cochran E, Bacci B, Chen Y, Patton A, Gambetti P, Autilio-Gambetti L. Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease. Am J Pathol 1991; 139: 485-9.
23. Craner MJ, Lo AC, Black JA, Waxman SG. Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination. Brain 2003a; 126: 1552-61.
24. Craner MJ, Kataoka Y, Lo AC, Black JA, Baker D, Waxman SG. Temporal course of upregulation of Nav1.8 in Purkinje neurons parallels the progression of clinical deficit in EAE. J Neuropathol Exp Neurolol. In press 2003b.
25. Davie CA, Barker GJ, Webb S, Tofts PS, Thompson AJ, Harding AE, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995; 118: 1583-92.
26. England JD, Gamboni F, Levinson SR, Finger TE. Changed distribution of sodium channels along demyelinated axons. Proc Natl Acad Sci USA 1990; 87: 6777-80.
27. Fern R, Ransom BR, Stys PK, Waxman SG. Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam. J Pharmacol Exp Ther 1993; 266: 1549-55.
28. Foster RE, Whalen CC, Waxman SG. Reorganization of the axon membrane in demyelinated peripheral nerve fibres: morphological evidence. Science 1980; 210: 661-3.
29. Ganter P, Prince C, Esiri MM. Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol 1999; 25: 459-67.
30. Garthwaite G, Goodwin DA, Batchelor AM, Leeming K, Garthwaite J. Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve. Neuroscience 2002; 109: 145-55.
31. Goldin AL, Barchi RL, Caldwell JH, Hofmann F, Howe JR, Hunter JC, et al. Nomenclature of voltage-gated sodium channels. Neuron 2000; 28: 365-8.
32. Gong B, Rhodes KJ, Bekele-Arcuri Z, Trimmer JS. Type I and type II Na+ channel alpha-subunit polypeptides exhibit distinct spatial and temporal patterning, and association with auxiliary subunits in rat brain. J Comp Neurol 1999; 412: 342-52.
33. Herzog RI, Cummins TR, Ghassemi F, Dib-Hajj S, Waxman SG. Distinct repriming and closed-state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons. J Physiol 2003; 551: 741-50.
34. Imaizumi T, Kocsis JD, Waxman SG. Resistance to anoxic injury in the dorsal columns of adult rat spinal cord following demyelination. Brain Res 1998; 779: 292-6.
35. Kaplan MR, Meyer-Franke A, Lambert S, Bennett V, Duncan ID, Levinson SR, et al. Induction of sodium channel clustering by oligodendrocytes. Nature 1997; 386: 724-8.
36. Kapoor R, Davies M, Smith KJ. Temporary axonal conduction block and axonal loss in inflammatory neurological disease. A potential role for nitric oxide? Ann NY Acad Sci 1999; 893: 304-8.
37. Kapoor R, Davies M, Blaker PA, Hall SM, Smith KJ. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann Neurol 2003; 53: 174-80.
38. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Bruck W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002; 125: 2202-12.
39. Lo AC, Black JA, Waxman SG. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis. Neuroreport 2002; 13: 1909-12.
40. Lo AC, Saab CY, Black JA, Waxman SG. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J Neurophysiol. In press 2003.
41. Lovas G, Szilagyi N, Majtenyi K, Palkovits M, Komoly S. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 2000; 123: 308-17.
42. Ma JY, Catterall WA, Scheuer T. Persistent sodium currents through brain sodium channels induced by G protein betagamma subunits. Neuron 1997; 19: 443-52.
43. Maurice N, Tkatch T, Meisler M, Sprunger LK, Surmeier DJ. D1/D5 dopamine receptor activation differentially modulates rapidly inactivating and persistent sodium currents in prefrontal cortex pyramidal neurons. J Neurosci 2001; 21: 2268-77.
44. Novakovic SD, Levinson SR, Schachner M, Shrager P. Disruption and reorganization of sodium channels in experimental allergic neuritis. Muscle Nerve 1998; 21: 1019-32.
45. Raman IM, Bean BP. Resurgent sodium current and action potential formation in dissociated cerebellar Purkinje neurons. J Neurosci 1997; 17: 4517-26.
46. Redford EJ, Kapoor R, Smith KJ. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 1997; 120: 2149-57.
47. Rios JC, Rubin M, St Martin M, Downey RT, Einheber S, Rosenbluth J, et al. Paranodal interactions regulate expression of sodium channel subtypes and provide a diffusion barrier for the node of Ranvier. J Neurosci 2003; 23: 7001-11.
48. Rosenbluth J. Role of glial cells in the differentiation and function of myelinated axons. Int J Dev Neurosci 1988; 6: 3-24.
49. Shrager P, Custer AW, Kazarinova K, Rasband MN, Mattson D. Nerve conduction block by nitric oxide that is mediated by the axonal environment. J Neurophysiol 1998; 79: 529-36.
50. Smith KJ, Bostock H, Hall SM. Saltatory conduction precedes remyelination in axons demyelinated with lysophosphatidyl choline. J Neurol Sci 1982; 54: 13-31.
51. Smith MR, Smith RD, Plummer NW, Meisler MH, Goldin AL. Functional analysis of the mouse Scn8a sodium channel. J Neurosci 1998; 18: 6093-102.
52. Smith KJ, Kapoor R, Felts PA. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 1999; 9: 69-92.
53. Smith KJ, Kapoor R, Hall SM, Davies M. Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 2001; 49: 470-6.
54. 2+ exchanger in mammalian myelinated axons. Brain Res 1997; 776: 1-9.
55. Stys PK, Lesiuk H. Correlation between electrophysiological effects of mexiletine and ischemic protection in central nervous system white matter. Neuroscience 1996; 71: 27-36.
56. Stys PK, Lopachin RM. Mechanisms of calcium and sodium fluxes in anoxic myelinated central nervous system axons. Neuroscience 1998; 82: 21-32.
57. 2+ influx during anoxia in mammalian central nervous system white matter. Ann Neurol 1991; 30: 375-80.
58. 2+ exchanger. J Neurosci 1992a; 12: 430-9.
59. Stys PK, Ransom BR, Waxman SG. Tertiary and quaternary local anaesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability. J Neurophysiol 1992b; 67: 236-40.
60. Stys PK, Sontheimer H, Ransom BR, Waxman SG. Noninactivating, tetrodotoxin-sensitive Na+ conductance in rat optic nerve axons. Proc Natl Acad Sci USA 1993; 90: 6976-80.
61. Tanaka M, Cummins TR, Ishikawa K, Black JA, Ibata Y, Waxman SG. Molecular and functional remodeling of electrogenic membrane of hypothalamic neurons in response to changes in their input. Proc Natl Acad Sci USA 1999; 96: 1088-93.
62. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. New Engl J Med 1998; 338: 278-85.
63. + channel subtypes in central neurons. Neuron 1989; 3: 695-704.
64. Whitaker WR, Clare JJ, Powell AJ, Chen YH, Faull RL, Emson PC. Distribution of voltage-gated sodium channel alpha-subunit and beta-subunit mRNAs in human hippocampal formation, cortex, and cerebellum. J Comp Neurol 2000; 422: 123-39.
65. Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, et al. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurolol 2002; 61: 23-32.
66. Young W. Role of calcium in central nervous system injuries. J Neurotrauma 1992; 9 Suppl 1: S9-25.